UnitedHealth Group reported second-quarter 2026 earnings of $6.38 per share, exceeding analyst expectations and prompting an upward revision of its full-year profit outlook. Despite rising medical costs and membership declines, the insurer is leveraging a $1.5 billion investment in artificial intelligence to improve operational efficiency and patient care.
Second-Quarter Financial Performance and 2026 Outlook
UnitedHealth Group posted a strong second quarter on July 16, 2026, delivering net income of $5.48 billion, or $6.04 per share. This performance marked a significant increase from the $3.41 billion, or $3.74 per share, recorded in the same period a year ago. Excluding specific items such as business divestitures and reserves for unprofitable contracts, the company earned $6.38 per share, significantly outpacing the $4.90 expected by Wall Street analysts, according to CNBC.
On the strength of these results, the company raised its full-year 2026 adjusted earnings outlook to a range of $19.50 to $20 per share, up from a previous projection of more than $18.25. While UnitedHealth maintained its revenue guidance of greater than $439 billion, CFO Wayne DeVeydt suggested in an interview that the company expects to do better than that
for the full year.
Operational Strategy and Artificial Intelligence Investment
The company is currently executing a turnaround plan focused on stabilizing margins through a combination of executive restructuring, the pruning of unprofitable contracts, and a $1.5 billion investment in artificial intelligence. As reported by the WSJ, this financial shift follows a period of instability and the return of CEO Stephen Hemsley to the top leadership role.
The firm is applying AI tools to streamline administrative tasks, such as prior authorizations, and to enhance payment accuracy by identifying fraud, waste, and abuse. DeVeydt emphasized that these tools are not used to make clinical coverage determinations.
“I would say the turnaround, and I would emphasize that on our culture, it’s really happening … that turnaround is translating to strong, strong earnings. So it shows that when we can do things the way we think they should be done, that we can be both a solution and be profitable.”
Rising Medical Costs and Membership Dynamics
These elevated costs are forcing the company to raise premiums, which has contributed to a decline in membership. UnitedHealthcare served 48.5 million people in the second quarter, a decrease of 525,000 from the previous quarter. The company projects a total loss of roughly 500,000 ACA exchange members and 1.1 million Medicare Advantage members for the year 2026. DeVeydt acknowledged the long-term implications of this pricing environment, stating that the current dynamic is not a good thing for the system long term.
Market Position and Analyst Expectations
UnitedHealth’s ability to consistently beat estimates has drawn attention from market observers. With a positive Earnings ESP (Expected Surprise Prediction) of +7.71% and a Zacks Rank of #2 (Buy), analysts have grown increasingly bullish on the firm’s near-term earnings potential, even as the company manages the ongoing challenges of rising utilization and expensive specialty drugs like GLP-1s.
Looking ahead, the company continues to navigate a multi-year journey
to optimize its operations. While the company faces ongoing scrutiny regarding its Medicare billing practices—a matter currently under Department of Justice investigation—it continues to report financial growth, with revenue climbing to $112.03 billion in the second quarter from $111.62 billion in the same period last year.
Find more reporting in our News section.
Related reading